This council has been reformed into the ISPOR Health Technology Assessment Council.


As developed by the Council meeting attendees:

“The mission of the ISPOR Health Care Strategy Council is to provide strategies to ISPOR on bridging the gap between outcomes research and health care decisions and to optimize health care decision using outcomes research.”


  • Education, Training, Communication Issues
  • Pricing, Market Force, Health Policy, and Applicability Issues
  • Methods & Standards Issues
  • Availability, Access, & Sharing Issues
  • Credibility, Integrity, Bias Issues


Laurie Beth Burke RPh, MPH
Office of New Drugs, Center for Drug Evaluation and Research (CDER), FDA, Rockville, MD, USA

Michael Drummond PhD
University of York, Centre for Health Economics, Heslington, York, UK

Eugene Eavy R.Ph., MBA
St. Joseph Mercy Health System, Ann Arbor, MI, USA>

Lauren Hoffman PharmD
Blue Cross Blue Shield of FL, Jacksonville, FL, USA

Andreas Laupacis MD, MSc, FRCPC
Institute for Clinical Evaluative Sciences, Toronto, Canada

James MacKay MD
Providence Health Plan, Beaverton, OR, USA

Christoph Straub MD
Techniker Krankenkasse, Hamburg, Germany

George Mayzell MD, MBA
Blue Cross/Blue Shield of Florida, Jacksonville, FL, USA

Dennis W Raisch PhD
Department of Veterans Affairs, Albuquerque, NM, USA

Joseph Singer, M.D.
HealthCore, Inc., Wilmington, Delaware, USA

Brian Sweet B.S. Pharm, MBA
WellPoint Pharmacy Management, West Hills, CA, USA

Marcus Wilson PharmD
Health Core, Inc., Wilmington, DE, USA